Who owns Enzo Biochem?
- Ticker: ENZ
- CUSIP Number: 294100102
Tip: Access positions for across all investors
Analyze quarterly positions in Enzo Biochem with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Enzo Biochem stock
Who bought or sold Enzo Biochem this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.9M | $2.4M | 0% | Mar 2024 |
|
| Potomac Capital Management | 1.5M | $2.1M | 2% | Dec 2023 |
|
| Tang Capital Management | 1.3M | $1.6M | -26% | Mar 2024 |
|
| BlackRock | 954k | $1.2M | 0% | Mar 2024 |
|
| Dimensional Fund Advisors | 656k | $833k | -10% | Mar 2024 |
|
| Geode Capital Management | 338k | $429k | 0% | Mar 2024 |
|
| Rbf Capital | 250k | $318k | 0% | Mar 2024 |
|
| Bridgeway Capital Management | 227k | $288k | 0% | Mar 2024 |
|
| Morgan Stanley | 72k | $91k | -5% | Mar 2024 |
|
| Wittenberg Investment Management | 68k | $86k | 100% | Mar 2024 |
|
| Northern Trust | 67k | $85k | -35% | Mar 2024 |
|
| Lazard Asset Management | 51k | $70k | 0% | Dec 2023 |
|
| T. Rowe Price Associates | 45k | $57k | 0% | Mar 2024 |
|
| Kempner Capital Management | 26k | $32k | 0% | Mar 2024 |
|
| Susquehanna International | 24k | $31k | 63% | Mar 2024 |
|
| Snowden Capital Advisors | 20k | $26k | 0% | Mar 2024 |
|
| Assenagon Asset Management | 20k | $25k | -73% | Mar 2024 |
|
| Paradigm Financial Partners | 20k | $25k | 0% | Mar 2024 |
|
| PFG Investments | 19k | $24k | 100% | Mar 2024 |
|
| Raymond James Trust | 17k | $22k | 0% | Mar 2024 |
|
| Shulman DeMeo Asset Management | 16k | $20k | 0% | Mar 2024 |
|
| XTX Topco | 15k | $18k | 100% | Mar 2024 |
|
| Sage Mountain Advisors | 14k | $18k | 0% | Mar 2024 |
|
| Charles Schwab Investment Management | 14k | $17k | 0% | Mar 2024 |
|
| Tower Research Capital | 12k | $15k | -22% | Mar 2024 |
|
| Nierenberg Investment Management Company | 12k | $15k | 0% | Mar 2024 |
|
| Covestor | 4.0k | $5.0k | 0% | Mar 2024 |
|
| BFSG | 2.8k | $3.6k | 100% | Mar 2024 |
|
| Bank of America Corporation | 2.4k | $3.0k | -23% | Mar 2024 |
|
| FMR | 2.0k | $2.5k | 562% | Mar 2024 |
|
| Jpmorgan Chase & Co | 1.8k | $2.3k | 0% | Mar 2024 |
|
| Advisor Group Holdings | 1.1k | $1.4k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 1.1k | $0 | -18% | Mar 2024 |
|
| Wells Fargo & Company | 882.00 | $1.1k | -32% | Mar 2024 |
|
| Simplex Trading | 881.00 | $1.0k | 100% | Mar 2024 |
|
| Benjamin Edwards | 300.00 | $0 | 0% | Mar 2024 |
|
| UBS Group | 278.00 | $353.004400 | -85% | Mar 2024 |
|
| Clear Point Advisors | 120.00 | $152.004000 | 0% | Mar 2024 |
|
| Sound Income Strategies | 10.00 | $13.000000 | 100% | Mar 2024 |
|
| Goss Wealth Management | 10.00 | $13.000000 | 0% | Mar 2024 |
|
Who sold out of Enzo Biochem?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| FNY Investment Advisers | Dec 2023 | 76k | $105k |
| Bank of New York Mellon | Dec 2023 | 26k | $36k |
| Millennium Management | Dec 2023 | 25k | $35k |
| AE Wealth Management | Dec 2023 | 20k | $26k |
| Jane Street | Dec 2023 | 12k | $16k |
| Advisory Services Network | Dec 2023 | 500.00 | $695.000000 |
| Focused Wealth Management | Dec 2023 | 110.00 | $152.999000 |